Novel polychaprolactone - tricalcium phosphate (PCL-TCP) scaffolds customized for reconstruction of dento-alveolar deformities
Promotie: dhr. A.B.K. Yeo, 14.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Novel polychaprolactone - tricalcium phosphate (PCL-TCP) scaffolds customized for reconstruction of dento-alveolar deformities
Promotor(s): prof.dr. Y. Rem, prof.dr. A. Sandham
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Novel polychaprolactone - tricalcium phosphate (PCL-TCP) scaffolds customized for reconstruction of dento-alveolar deformities
In this thesis, a series of in vitro and in vivo experiments were designed to evaluate the prospective use of polycaprolactone-tricalcium phosphate (PCL-TCP) scaffolds, a synthetic bone substitute material, tailored for dentoalveolar ridge augmentation. We concluded that selective modification via pretreatment using sodium hydroxide improved PCL-TCP scaffold surface characteristics and enhanced overall bone formation. In addition, favorable interconnectivity and mechanical properties of the scaffold were maintained whilst undergoing degradation. Additional studies are required to further investigate the potential of PCL-TCP scaffolds involving clinically relevant defects using large animal jaw models.
Last modified: | 13 March 2020 01.14 a.m. |
More news
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.